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Abstract
Background: Patellofemoral joint (PFJ) osteoarthritis (OA) is prevalent in middle-aged and older adults. Despite this,
there are minimal studies which have examined conservative interventions for PFJ OA. Weakness of proximal lower
extremity muscles is associated with PFJ OA. It is unknown if a hip muscle strengthening and lumbopelvic-hip core
stabilization program will improve symptoms and function in persons with PFJ OA. This study examined the
feasibility and impact of a 6-week hip muscle strengthening and core stabilization program on pain, symptoms,
physical performance, peak muscle torques, and quality of life in persons with PFJ OA.
Methods: Ten females with PFJ OA and ten age- and sex-matched controls participated in baseline tests. PFJ OA
participants attended ten twice-a-week hip strengthening and core stabilization exercise sessions. Outcome
measures included questionnaires, the Timed-Up-and-Go, and peak isometric torque of hip and quadriceps muscles.
Data were tested for normality; parametric and non-parametric tests were used as appropriate.
Results: At baseline, the PFJ OA group had significantly worse symptoms, slower Timed-Up-and-Go performance,
and lower muscle torques than control participants. PFJ OA group adherence to supervised exercise sessions was
adequate. All PFJ OA participants attended at least nine exercise sessions. Five PFJ OA participants returned 6-
month follow-up questionnaires, which was considered fair retention. The PFJ OA participants’ self-reported pain,
symptoms, function in daily living, function in sport, and quality of life all improved at 6 weeks (P < 0.05). Timed-Up-
and-Go time score improved at 6 weeks (P = 0.005). Peak hip external rotator torque increased (P = 0.01).
Improvements in pain and self-reported function were no longer significant 6 months following completion of the
intervention.
Conclusions: PFJ OA participants were adherent to the supervised sessions of the intervention. Improvement in
symptoms, physical performance, and muscle torque were found after 6 weeks. Participant retention at 6 months was
fair, and significant changes were no longer present. Our findings suggest that a hip strengthening and core
stabilization program may be beneficial to improve symptoms, function, and physical performance in persons with PFJ
OA. Future studies are needed, and additional measures should be taken to improve long-term adherence to exercise.
Trial registration: ClinicalTrials.gov NCT02825238. Registered 6 July 2016 (retrospectively registered).
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Background
Knee osteoarthritis (OA) is a prevalent condition that
causes significant pain, reduced quality of life, and dis-
ability [1–4]. More than 9 million adults in the USA
have symptomatic knee OA, and this prevalence is in-
creasing [3, 5]. Symptomatic knee OA age-standardized
prevalence was reported to be 3.8% of the world’s popu-
lation [2]. Knee OA and hip OA together are reported to
be the 11th highest contributor to global disability [2].
The patellofemoral joint (PFJ) is a frequent site of knee
OA [6–8]. The PFJ is the knee compartment most com-
monly affected by OA [8–10]. Patellofemoral joint OA
was present in 39% of persons aged ≥ 30 years who re-
ported knee pain [11]. The prevalence of PFJ OA may be
even greater in persons with chronic PFJ pain. One
study reported that PFJ OA was present in 69% of per-
sons with chronic PFJ pain aged ≥ 40 years [8]. Isolated
PFJ OA is associated with significant pain and disability,
perhaps to an even greater degree than tibiofemoral joint
(TFJ) OA [6, 12, 13]. The presence of even mild radio-
graphic PFJ OA was associated with difficulty in activ-
ities requiring knee flexion during weight-bearing [12].
Activities reported as being most difficult for persons
with PFJ OA include descending and ascending stairs,
the sit-to-stand transfer, getting in and out of the
bathtub, and getting in and out of a car [12]. Clinical
features of PFJ OA may include anterior knee pain, a
history of significant swelling, genu valgus malalignment,
quadriceps muscle weakness, hip abductor weakness,
abnormal pelvic and lower extremity (LE) biomechanics,
and pain with PFJ compression [14–20]. Females with
PFJ OA are reported to rate their pain as more severe
compared to males with the same level of radiographic
PFJ OA [21].
Management guidelines for knee OA have been pub-
lished by several international organizations [22–26]. Two
systematic reviews of OA management guidelines reported
strong evidence for beneficial effects of the following non-
pharmacologic interventions: exercise, education, self-
management, weight loss, manual therapy, assistive walking
devices, thermal modalities, and electrical stimulation mo-
dalities [22, 23]. Exercise and education were reported to be
the interventions with the strongest evidence of efficacy
and to be relatively inexpensive [23]. Aerobic, strengthen-
ing, aquatic, and general exercise have all been shown to be
beneficial for persons with knee OA [24–28]. However, evi-
dence for the most effective type of exercise for knee OA is
currently lacking [29]. In addition, there are different knee
OA phenotypes, for which optimal management may differ
[30–34]. Patellofemoral OA may require different interven-
tions than TFJ OA, given significant differences in joint bio-
mechanics, cartilage structure, risk factors, muscle strength,
and aggravating activities [15, 35, 36]. It has been proposed
that a treatment program targeting the pathomechanics of
PFJ OA may be more efficacious than a standard interven-
tion for knee OA [37].
Despite the high prevalence, significant pain, and func-
tional limitations caused by PFJ OA, there is a paucity of
evidence for conservative treatment of this disabling con-
dition. Studies examining exercise interventions for knee
OA have frequently targeted the TFJ rather than the PFJ
[38–41]. Currently, there are limited reports of non-
surgical physical interventions specifically designed for
PFJ OA [42–46]. Studies examining exercise as an inter-
vention for PFJ OA have used a multimodal approach in-
cluding manual therapy, education, and modalities [42,
45]. Quilty et al. [42] reported that a program of quadri-
ceps strengthening exercise and medial patellar taping
produced short-term improvement in knee pain and
quadriceps strength compared to a control group that re-
ceived no physiotherapy; however, these differences were
no longer significant after 12 months. Crossley et al. [45]
reported that a multimodal program of manual therapy,
education, patellar taping, and exercise resulted in im-
proved pain intensity and patient-perceived change com-
pared to an education-only group. The exercise program
used by Crossley et al. [45] included open- and closed-
kinetic chain quadriceps strengthening, side lying hip ab-
ductor strengthening, and functional retraining of the
vasti and/or hip abductor muscles during sitting, sit-to-
stand, stepping up, and/or single-leg-squats. Differences in
pain and patient-perceived change were no longer present
6 months following completion of the 3-month treatment
session [45]. No differences between groups were found
for self-reported function or actual physical performance
in either study [42, 45]. Importantly, it is unknown which
component(s) of these multimodal interventions were re-
sponsible for the short-term benefits.
Although limited evidence exists for the impact of ex-
ercise on pain, impairments, and disability in PFJ OA,
substantial evidence is present for the beneficial effect of
strengthening exercise for patellofemoral pain (PFP) in
younger adults [47–56]. Patellofemoral pain in adoles-
cence and young adulthood may be a possible predispos-
ing factor to PFJ OA [57, 58]. Similar LE muscle
weakness is present in both conditions, most notably the
quadriceps, hip extensor, hip abductor, and hip external
rotator muscles [14, 20, 59–63]. Altered pelvic and hip
biomechanics during functional activities and impaired
lumbopelvic-hip postural stability, i.e., core stability, has
been reported in PFJ OA and PFP [19, 64–67]. Recent
systematic reviews reported conflicting results regarding
the superiority of quadriceps strengthening versus hip
muscle strengthening in terms of pain relief in persons
with PFP [53, 56, 68]. Alba-Martin et al. [53] reported
that programs of hip abductor and hip external rotator
muscle strengthening combined with quadriceps
strengthening resulted in earlier pain relief compared to
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quadriceps strengthening alone in persons with PFP. A
systematic review and meta-analysis of proximal muscle
rehabilitation for PFP reported that programs including
strengthening of the hip abductors, hip external rotators,
and hip extensors were superior to quadriceps strength-
ening programs for pain reduction in the short and
medium terms as well as improved function in the
medium term [68]. Thomson et al. [56] reported that
hip-focused and knee-focused strengthening programs
were both effective to reduce PFP. But a program of
combined hip and quadriceps muscle strengthening was
superior to quadriceps strengthening alone in terms of
reduced pain intensity and improved function in the
short, medium, and longer terms for persons with PFP
[68]. Hip strengthening programs for PFP frequently in-
clude activities to promote core stabilization, including
many studies in the systematic review by Thomson et al.
[51, 52, 56, 69–74] More recently, females with PFP
treated with core stabilization exercises combined with
knee-focused exercise resulted in less pain, better self-
reported function, and better physical performance on
the Timed-Up-and-Go and a hop test compared to a
group treated with only knee-focused exercise [75].
Proximal LE strength and core stability have been pro-
posed to be important as a stable foundation for LE move-
ment in closed chain functional activities [76]. A recent
expert consensus statement reported that persons with PFP
have reduced hip and trunk muscle strength as well as al-
tered trunk and LE kinematics during functional activities
[77]. It is proposed that altered trunk and hip kinematics
may cause altered tibiofemoral and/or patellar kinematics,
with resultant increased PFJ stress and PFP [77]. Strength-
ening hip muscles and improving lumbopelvic-hip core sta-
bility may reduce reliance on the quadriceps muscle during
flexed knee activities, thus reducing PFJ stress and PFP
[36]. Reduction of PFJ stress may be critical to achieve pain
relief and facilitate exercise participation in persons with
PFJ OA [68]. It is currently unknown if a program of
strengthening exercises for the hip external rotators, hip ab-
ductors, and hip extensors combined with lumbopelvic-hip
core stabilization exercises and education to promote core
stability will be effective at decreasing knee pain, improving
function, and improving quality of life (QOL) in persons
with painful PFJ OA.
The aim of this study was to determine the feasibility
and effect of a program including hip and core muscle
strengthening, core stabilization, and LE alignment
neuromuscular education for persons with PFJ OA on
knee pain, self-reported function, physical performance,
and QOL compared to baseline.
Methods
A pre-post intervention design was used for this proof
of concept, feasibility pilot study [78]. The primary
objectives were to (1) estimate adherence to the super-
vised exercise program, (2) estimate long-term retention
rate and willingness to respond to a 6-month follow-up,
and (3) establish the viability of the treatment model
through the impact on participants’ pain ratings, activity
of daily living (ADL), and global rating of change after
the 6-week supervised program. Secondary objectives of
this study were to (1) assess the impact of the interven-
tion on physical performance, (2) determine the long-
term benefits of the intervention in terms of self-
reported pain and function at a 6-month follow-up, and
(3) assess the impact of the intervention on hip and knee
muscle torques.
Participants
Ten persons with painful PFJ OA were recruited from
an orthopedic surgeon (JK) at the Department of Sports
Medicine at the University of Pennsylvania and in re-
sponse to recruitment posters placed at the University of
the Sciences and the local community. Potential partici-
pants were screened for eligibility with a questionnaire
by the lead investigator (LH). Persons who appeared to
satisfy all study inclusion and exclusion criteria for the
PFJ OA group were screened for the presence of radio-
graphic PFJ OA on knee diagnostic imaging studies by
an orthopedic surgeon (JK) trained in use of the Osteo-
arthritis Research Society International (OARSI) grading
scale [79, 80]. Potential participants who passed both
phases of screening were invited to participate in the
study (PFJ OA group). An additional cohort of 10 age-
and sex-matched asymptomatic control participants
were recruited for comparison to baseline PFJ OA group
status (control group). Testing and the intervention took
place in the research laboratories at the University of the
Sciences Department of Physical Therapy.
Inclusion criteria for the PFJ OA group were (1) aged
35–70 years, (2) diagnosed by a medical physician with
knee OA in one or both knees with symptoms primarily
in the anterior knee, (3) an OARSI OA grade of 1 or
more at the PFJ on diagnostic images (0 = none, 1 =
mild/possible, 2 =moderate/definite, 3 = severe) [79, 80],
(4) presence of ≥ 2 of the following: pain produced by
descending steps, ascending steps, sit-to-stand, squat-
ting, kneeling, prolonged knee flexion, increased activity
(e.g., hiking); morning stiffness < 30 min; stiffness after
sitting ≥ 30 min; or a history of patellar subluxation or
dislocation in the past [20, 58, 81]. Exclusion criteria
were (1) presence of other conditions that may cause
knee pain, (2) neurologic or musculoskeletal conditions
that may alter LE strength or movement, (3) history of a
knee joint fracture, (4) pregnancy, (5) knee injections
within the previous 3 months, and (6) inability to under-
stand English. Control group inclusion criteria were (1)
aged 35–70 years, (2) no known diagnosis of knee OA,
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(3) pain-free LE at time of enrollment and for 1 week
prior. Exclusion criteria for the control group included
(1) all exclusion criteria for the PFJ OA group, (2) pres-
ence of ≥ 2 of the following: a history of patellar sublux-
ation or dislocation, and pain produced by descending
steps, ascending steps, sit-to-stand, squatting, kneeling,
and prolonged knee flexion. Control group participants
were matched to PFJ OA group participants according
to sex and age (± 10 years).
All participants signed a written informed consent
prior to inclusion in the study, and the research was per-
formed in accordance with the Declaration of Helsinki.
The study was approved by the University of the Sci-
ences Institutional Review Board (IRB) and by the Uni-
versity of Pennsylvania IRB, Philadelphia, Pennsylvania,
USA.
Procedure
Potential PFJ OA group participants were identified for
possible eligibility by an orthopedic surgeon from clin-
ical practice (JK). Additional potential participants
responded to recruitment posters. All participants of
both groups were screened with a screening question-
naire. Diagnostic imaging studies of the knees of poten-
tial PFJ OA group participants were reviewed and
graded to confirm the presence of at least OARSI Grade
1 PFJ OA. Following admission to the study, subjects
read the informed consent form, had any questions re-
garding the study procedures answered, and gave written
informed consent. Participants rated their knee pain in-
tensity with an 11-point numeric pain rating scale
(NPRS), with 0 = no pain and 10 = worst pain imagin-
able. The NPRS is reported to be reliable and valid in
persons with knee OA [82, 83]. A change of 2 points on
the NPRS is clinically significant in persons with chronic
pain [84]. Participants completed the Knee Injury and
Osteoarthritis Outcome Score (KOOS), a patient-
reported measure of symptoms and function in persons
with knee injury and knee OA [85]. The KOOS is reli-
able, valid, and responsive to change for persons with
knee OA [86]. The KOOS contains five subscales: pain,
symptoms, ADL, sport/recreation, and QOL. Each sub-
scale includes several items, scored with a 5-point
Likert-scale score (0 = no pain/full function, 4 = extreme
pain/worst function). The mean subscale score is divided
by 4; the result is multiplied by 100; this figure is sub-
tracted from 100 to determine the resultant subscale
score (100 = least pain/best function possible). The
KOOS subscale minimum clinically important differ-
ences (MCID) were reported to be 8–10 points for each
subscale in persons with knee injury or osteoarthritis
[87]. More recently, KOOS subscale changes of 14.3–19.
6 points were reported to indicate true change in youn-
ger patients with knee injury treated conservatively [86].
For the purposes of this feasibility study, the KOOS pain
and ADL subscale scores were considered most critical.
Participants were examined to determine height,
weight, knee joint line height, and tenderness to palpa-
tion of the patella and patellar tendon. Participants’
physical performance was assessed with the Timed-Up-
and-Go (TUG), a timed test of a person’s ability to stand
from a chair, walk 3 m, turn, walk back, and sit back
down [88, 89]. The TUG includes the sit-to-stand trans-
fer, one of the activities reported to be most impaired in
persons with PFJ OA, perhaps due to high PFJ stress
from strong quadriceps contraction with the knee in a
highly flexed position [12, 13]. Persons with bilateral PFJ
OA required significantly longer time to complete the
TUG compared to a pain-free control group without
radiographic PFJ OA [13]. The TUG is valid and respon-
sive to change in persons with knee OA and is recom-
mended by OARSI as one of the core physical
performance outcome measures in persons with knee
OA [89–91]. The MCID for the TUG in persons with
knee OA is reported to be 0.8–1.4 s [90]. Participants
performed one practice trial followed by three timed tri-
als of the TUG. The average of three trials was used as
the result. Participants reported a pre- and post-TUG
NPRS for knee pain [92].
Strength of the knee extensor, hip abductor, hip exten-
sor, and hip external rotator muscles were examined
with a peak isometric muscle torque test using the BTE
Primus RS™ dynamometer (BTE Technologies, Inc.,
Hanover, MD, USA) [93–96]. The Primus RS™ was
shown to have excellent intrarater test-retest reliability
for LE muscle tests using this methodology [96]. Peak
torques were normalized according to height and weight
with the formula Nm torque/(kg mass × height in me-
ters) [97]. Muscle torque tests were three maximal effort
isometric trials, 3 s in length, with a rest of 30 s between
trials. The average of three trials was used as the result.
Stabilizing straps were used to maintain participants in
the test position. Participants performed two submaxi-
mal practice trials prior to recorded trials to familiarize
them with the test. Participants were instructed to exert
maximal effort and were verbally coached to push as
hard as they could for each recorded trial. Trials were
repeated if compensatory motion was observed or if the
coefficient of variation for the three recorded trials was
> 10% [96]. The order of muscle torque testing was ran-
domized with a random number generator to prevent an
order effect.
Hip abductor test position had the participant side
lying with the tested LE uppermost with the hip and
knee in the anatomical neutral position, opposite LE hip
and knee flexed to approximately 45° each [93–95]. The
trunk was stabilized with straps, dynamometer axis of
rotation was opposite the uppermost gluteus maximus
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at the level of the greater trochanter, and the resistance
pad was positioned on the distal lateral thigh 2.5 cm
proximal to the lateral femoral epicondyle (Fig. 1a). Hip
extensor test position had the participant prone with the
tested LE at anatomical neutral hip position, tested knee
flexed to approximately 80°, dynamometer axis of rota-
tion opposite the tested LE greater trochanter,
stabilization straps at the trunk and contralateral thigh,
and the resistance pad at the posterior distal thigh of the
tested LE (Fig. 1b) [93–95]. Hip external rotator test
position had the participant seated with the hip at 90°
flexion and neutral frontal and transverse plane rotation,
knee flexed to 90°, dynamometer axis of rotation oppos-
ite the anterior knee in line with the femoral shaft longi-
tudinal axis, stabilization straps at the distal thigh and
trunk, and the resistance pad positioned on the medial
lower leg 5 cm proximal to the medial malleolus (Fig.
1c) [96]. Knee extensor peak torque test position was
with the participant seated with the hip at 90° flexion
and neutral frontal and transverse plane position, knee
flexed to 60°, dynamometer axis of rotation opposite the
lateral femoral epicondyle, stabilization straps at the dis-
tal thigh and trunk, and the resistance pad positioned on
the anterior lower leg 5 cm proximal to the lateral mal-
leolus (Fig. 1d) [98].
Rehabilitation protocol
Patellofemoral OA group subjects participated in a super-
vised exercise program. This novel intervention included
progressive strengthening of the hip and core muscles,
biofeedback to promote lumbopelvic-hip core stability,
and neuromuscular reeducation to promote proper LE
alignment during functional activities. Since the hip ab-
ductor, hip extensor, and hip external rotator muscles have
been shown to be weak in persons with PFJ OA and in
younger persons with PFP, the program initially focused
on exercises to target strengthening those muscle groups.
Treatment began primarily in a recumbent position to
minimize recruitment of the quadriceps muscle and to
minimize PFJ reaction forces and PFJ stress [70]. During
the last 2 weeks of the program, exercises progressed to a
more functional, weight-bearing position, including train-
ing in proper lumbopelvic-hip and knee alignment to
avoid dynamic genu valgus and contralateral pelvic drop-
ping. Quadriceps muscle strengthening likely occurred
during weight-bearing exercises, but no exercises specific-
ally targeting the quadriceps were utilized.
The rehabilitation program consisted of an initial evalu-
ation session, 10 supervised exercise sessions over the
course of 5–6 weeks, and a re-evaluation session. Sessions
were provided two times per week for 6 weeks, with one
exercise session in weeks 1 and 6 and two exercise ses-
sions in weeks 2–5. Participants were allowed up to
8 weeks if necessary to complete all sessions, depending
upon availability and scheduling. Exercise sessions were
approximately 60-min duration. The supervised exercise
program was based on progressive strengthening of hip
and core muscles, lumbopelvic-hip core stabilization and
endurance during destabilizing activities, stretching of LE
muscles reported to be tight in PFP [99], auditory and vis-
ual feedback to improve core stabilization during func-
tional activities, and neuromuscular reeducation to avoid
Fig. 1 Peak isometric muscle torque testing positions. a–d The positions of participants during testing. a Hip abductor test position. b Hip
extensor test position. c Hip external rotator test position. d Knee extensor test position
Hoglund et al. Pilot and Feasibility Studies  (2018) 4:70 Page 5 of 14
excessive knee abduction, hip adduction, and hip internal
rotation during weight-bearing activities and ADL. Partici-
pants were instructed to maintain a level pelvis during sin-
gle leg stance activities, to keep their knee centered over
their second toe, and to avoid allowing their knees to
move excessively inwards or outwards during weight-
bearing exercises and activities (sit-to-stand practice,
lunges, etc.). Exercise sessions were supervised by licensed
physical therapists and by student physical therapists
trained in the protocol by the principal investigator. Re-
sistance load was determined by participants’ ability to
perform exercises with good core stabilization and LE
control, without increase in knee pain, and without pro-
duction of pain in other body regions [45, 100]; this was
determined by the supervising physical therapist or princi-
pal investigator. Participants were instructed in a home
exercise program to supplement the supervised sessions
and given written instructions, an exercise diary, and
therapeutic resistance tubing of various levels, as appro-
priate. The exercise program changed on a weekly basis
throughout the supervised exercise portion of the program
and participants were given new written, pictorial, and ver-
bal instructions each week. Participants were instructed in
a maintenance home exercise program at the conclusion of
the supervised sessions. An additional file shows the exer-
cise program in more detail (see Additional file 1).
Outcome measures at the 6-week follow-up of the PFJ
OA group included (1) the KOOS questionnaire; (2) the
TUG physical performance test; (3) tests of peak isomet-
ric torque of the hip abductors, hip extensors, hip exter-
nal rotators, and knee extensors; and (4) a global rating
of change (GRC). The GRC is a general self-report
measure of overall change scored from − 5 to 5 with an-
chors of “very much worse” (− 5), “unchanged” (0), and
“completely recovered” (5) [101]. A change of 2 points
on this 11-point scale is considered to be the MCID
[101]. Participants were asked to rate their change with
respect to their PFJ OA from the time immediately be-
fore beginning the supervised exercise program to the
conclusion of the 6-week supervised exercise program.
Patellofemoral joint OA group participants continued
the maintenance home exercise program for 6 months fol-
lowing completion of the supervised exercise program.
Exercise reminders were sent to participants as mobile de-
vice text messages or email messages on a monthly-
bimonthly basis. Six months following completion of the
supervised exercise program, PFJ OA group participants
were mailed a KOOS questionnaire and asked to complete
this and return it with the exercise diary.
Statistical analysis
Descriptive statistics were used to summarize the data.
Quantitative data were reported as percentages, numeric
counts, mean ± standard deviation (SD), or median and
interquartile range (IQR). Exploratory comparisons be-
tween the PFJ OA group and the control group at base-
line were conducted using either a t test, if the normality
assumption was met by the data, or Wilcoxon Rank
Sum test, otherwise. An exploratory analysis was also
performed to assess the changes in outcome variables
from baseline to 6 weeks for the PFJ OA group using
paired t tests, if the normality assumption was met by
the data, or Wilcoxon signed rank tests, otherwise. The
baseline to 6-month and 6-week to 6-month changes in
outcome variables for the PFJ OA group were assessed
with Wilcoxon signed rank tests. A P value less than 0.
05 was considered statistically significant. All statistical
analyses were performed using SAS version 9.4 (SAS In-
stitute, Inc. Cary, NC, USA).
Results
All 20 study participants were female. Participants
ranged in age from 37 to 65 years (PFJ OA group 41–
64 years, control group 37–65 years). There was no sig-
nificant difference in age between groups (Table 1). The
PFJ OA group was significantly heavier and had a signifi-
cantly greater body mass index (BMI) than the control
group (Table 1). Radiographic OA severity in the PFJ
OA group ranged from mild to moderate for the PFJ
(Table 2). Mild to moderate TFJ OA was present in
some of the PFJ OA participants as well (Table 2). At
baseline, the PFJ OA group had significantly greater pain
compared to the control group, as measured by the
NPRS and the KOOS pain subscale (Table 3). The PFJ
OA group had greater symptoms, lower function in
ADL and sport, and lower QOL at baseline versus the
control group, as measured with the KOOS (Table 3).
The PFJ OA group also had significantly lower peak iso-
metric muscle torque at baseline compared to the con-
trol group (Table 3). PFJ OA group participants required
longer time to complete the TUG at baseline than did
control group participants, and reported significantly
greater pre- and post-TUG pain (Table 3).
Eighteen persons were screened for participation in
the PFJ OA group exercise intervention; 10 of these 18
potential subjects participated in the study (55.6% par-
ticipant yield). Screen failures or reasons for non-
participation for the PFJ OA group included viscosup-
plementation knee injection within the previous
3 months (1 potential participant), neuromuscular co-
morbidity (1), history of bony patellofemoral realign-
ment surgery (1), radiographs older than 1 year (1), no
physician diagnosis of knee OA (1), and declined/did not
contact the principal investigator (3). The intervention
was acceptable to persons with PFJ OA: only 3 of 13 po-
tential PFJ OA group participants who met all inclusion
and exclusion criteria declined to participate; the PFJ
OA participation rate for those meeting all study criteria
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was 76.9%. Adherence to the supervised exercise pro-
gram was good: 9 participants attended all 12 supervised
sessions and 1 participant attended 11 sessions, only
missing 1 exercise session. There were no adverse reac-
tions attributable to the exercise intervention.
The long-term retention rate over 6 months following
the intervention and willingness to respond to a 6-month
follow-up was fair-poor. Only 5 participants returned the
KOOS questionnaire for a 50.0% retention rate, which was
considered fair. One participant dropped out of the study
after completion of the 6-week supervised exercise pro-
gram but before the 6-month follow-up since she elected
to have a surgical procedure on the index knee (reported
when contacted with an exercise reminder). Excluding the
participant who had surgery, the 6-month follow-up re-
tention rate for completion of the KOOS was 55.6%. Only
2 participants returned the exercise calendar, which was
considered poor. One exercise calendar was not com-
pleted at all while 1 exercise calendar was completed for
the 6-week supervised exercise sessions and for the
6 months of follow-up (3–5 sessions per week during the
6-week supervised session time period and 3 sessions per
week during the 6-month follow-up time period). It is un-
known if participants who did not return their exercise
calendar diaries completed them.
The PFJ OA group significantly improved in the short
term on the NPRS and on all KOOS subscales; all of the
baseline to 6-week changes in these variables surpassed
the MCID values (Table 4). The PFJ OA group GRC im-
mediately following the intervention was 2.70 ± 0.67
(mean ± SD), which is higher than the MCID of 2 points
[101]. Physical performance on the TUG significantly
improved at the 6-week follow-up compared to baseline;
the improvement in time surpassed the MCID of 0.8 s
(Table 5). Peak isometric muscle torque significantly im-
proved for the hip external rotators (Table 5). Isometric
muscle torque increased for the other muscle groups,
but differences did not reach statistical significance
(Table 5). Baseline to 6-week median changes in hip ex-
ternal rotator and hip extensor peak isometric muscle
torque were both greater than 14% increase, the re-
ported standard error of measurement for hip isometric
muscle strength and recommended value for minimum
important difference for the hip muscles [102]. The me-
dian baseline to 6-week change in knee extensor peak
isometric muscle torque was a 14% increase, which is
below the recommended minimum knee extensor
strength gain necessary to result in reduced disability
(40% gain) and to result in reduced pain (30% gain) [103].
Long-term response to the exercise intervention was
measured with the KOOS questionnaire. Although the 5
participants who completed and returned the KOOS still
had subscale scores greater than baseline, the scores had
declined since the 6-week follow-up. Change in KOOS
subscale scores between the 6-month follow-up and
baseline was no longer significant for any subscale
(median [IQR] KOOS subscale change baseline to
6-month follow-up: pain = 13.89 [0, 25.00], symptoms =
Table 1 Demographic characteristics of participants (n = 20,
100% female)
PFJ OA group Control group P value
Age (years) 50 (46, 56) 52 (49, 56) 0.6415
Height (m) 1.64 (1.60, 1.69) 1.67 (1.58, 1.73) 0.8677
Weight (kg) 102.35 (75.70, 112.30) 66.55 (60.80, 70.70) 0.0007
BMI 33.04 (28.28, 41.02) 23.41 (22.51, 27.09) 0.0021
History of patellar
subluxation
or dislocation (n)
1 (dislocation) 0 –
Data are expressed as median (IQR). Values in italics indicate significant
differences at the 0.05 significance level in the exploratory analyses (Wilcoxon
Rank Sum test)
n number, PFJ OA patellofemoral joint osteoarthritis, BMI body mass index, IQR
interquartile range
Table 2 Diagnostic imaging characteristics for patellofemoral
joint osteoarthritis group participants, frequency (n = 10, 100%
female)
Patellofemoral joint
OARSI grade 0 1 2 3
JSN Medial 5 2 2 0
Lateral 5 4 0 0
Marginal osteophytes Medial 3 3 0 0
Lateral 2 3 1 0
Superior 3 6 1 0
Inferior 6 4 0 0
Subchondral bony sclerosis Medial 3 2 0 0
Lateral 2 2 1 0
Subluxation Medial 6 0 0 0
Lateral 4 2 0 0
Tibiofemoral joint
OARSI grade 0 1 2 3
JSN Medial 6 2 1 0
Lateral 6 3 0 0
Marginal osteophytes Medial 8 0 1 0
Lateral 8 1 0 0
Subchondral bony sclerosis Medial 4 5 0 0
Lateral 8 1 0 0
None Varus Valgus
Tibiofemoral malalignment 6 2 1 –
Total may not equal total number participants due to missing data/
radiographic views for some participants
n number, OARSI Osteoarthritis Research Society International (0 = none, 1 = mild,
2 = moderate, 3 = severe), JSN joint space narrowing
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10.71 [10.71, 21.43], ADL = 11.76 [5.88, 17.65], sport/re-
creation = 15.00 [0, 40.00], QOL = 25.00 [0, 37.50]; all
P > 0.05). All KOOS subscale change scores from base-
line to 6-month follow-up were still greater than the
MCID of 8–10 points, however. Change in KOOS sub-
scale scores between the 6-week follow-up and the 6-
month follow-up was no longer significant for any sub-
scale (median [IQR] KOOS subscale change 6-week
follow-up to 6-month follow-up: pain = 0.00 [− 5.56, 2.
78], symptoms = − 3.57 [− 10.71, 0.00], ADL = − 4.41 [−
9.74, − 1.47], sport/recreation = 0 [− 5.00, 5.00], QOL =
− 6.25 [− 18.75, − 6.25]; all P > 0.05).
Discussion
This study is the first to our knowledge to examine the
effect and feasibility of a hip and core muscle strength-
ening and stability exercise program as an intervention
for persons with painful PFJ OA. Participants found the
supervised exercise program acceptable, with all PFJ OA
group participants attending the baseline assessment, 6-
week follow-up session, and at least nine of ten exercise
sessions. The retention rate for the 6-month follow-up
was not as favorable with only 50% of the PFJ OA group
returning a completed KOOS questionnaire and only
20% returning an exercise calendar diary. Only 1 of these
exercise diaries was completed. It is unknown if partici-
pants who did not return their exercise diaries com-
pleted them. Participants who returned the KOOS at the
6-month follow-up generally had lower pain and symp-
toms and better function than prior to the exercise inter-
vention, but their self-reported status was no longer
significantly improved compared to baseline. However,
the baseline to 6-month follow-up changes were still
greater than the MCID for all subscales of the KOOS,
indicating that the changes may have been clinically
important [87]. It is possible that the positive change
from baseline to the 6-months follow-up would have
been statistically significant if all participants returned
Table 3 Baseline test results, comparison between groups
PFJ OA group Control group P value
KOOS Pain (0–100) 63.89 (47.22, 66.67) 100 (100, 100) < 0.0001
KOOS Symptom (0–100) 60.71 (53.57, 67.86) 98.21 (92.86, 100) < 0.0001
KOOS ADL (0–100) 68.38 (47.06, 76.47) 100 (100, 100) < 0.0001
KOOS Sport/Rec (0–100) 30 (20, 50) 100 (100, 100) 0.0001
KOOS QOL (0–100) 37.50 (25, 43.75) 100 (100, 100) < 0.0001
NPRS (0–10) 3 (3, 6) 0 (0, 0) 0.0001
Hip Ext Rot Torque 0.15 ± 0.02 0.24 ± 0.07 0.0010
Hip Abd Torque 0.33 (0.31, 0.41) 0.48 (0.43, 0.59) 0.0007
Hip Ext Torque 0.11 (0.07, 0.21) 0.27 (0.20, 0.43) 0.0089
Knee Ext Torque 0.43 (0.37, 0.62) 0.77 (0.72, 0.87) 0.0089
TUG (s) 7.42 (6.46, 8.55) 5.88 (5.09, 5.96) 0.0336
Pre-TUG Pain (0–10) 2.00 (0.00, 4.00) 0 (0, 0) 0.0031
Post-TUG Pain (0–10) 2.00 (1.00, 4.00) 0 (0, 0) 0.0007
Data are expressed as median (IQR) except for Hip Ext Rot Torque, which is expressed as mean ± SD. Values in italics indicate significant differences at the 0.05
significance level in the exploratory analyses (Wilcoxon Rank Sum test [median {IQR} results] or two-sample t test [mean ± SD] results). KOOS scored from 0 to 100,
100 = best status. NPRS scored from 0 to 10, 10 = worst pain
PFJ OA patellofemoral joint osteoarthritis, KOOS Knee Injury and Osteoarthritis Outcome Score, ADL activity of daily living, Rec recreation, QOL quality of life, NPRS
numeric pain rating scale, Ext Rot external rotator, Abd abductor, Ext extensor, TUG Timed-Up-and-Go, IQR interquartile range, SD standard deviation
Table 4 PFJ OA participant pain rating and KOOS scores: baseline, 6-week follow-up, and change (n = 10)
Baseline 6-week follow-up Participant score change from baseline P value
NPRS (0–10) 3 (3, 6) 1 (0, 3) − 2.50 (− 3, − 2) 0.0195
KOOS Pain (0–100) 63.89 (47.22, 66.67) 77.78 (69.44, 86.11) 16.67 (5.56, 25.00) 0.0039
KOOS Symptom (0–100) 60.71 (53.57, 67.86) 75.00 (57.14, 89.29) 14.29 (10.71, 17.86) 0.0156
KOOS ADL (0–100) 68.38 (47.06, 76.47) 83.82 (79.41, 94.12) 15.44 (14.71, 17.65) 0.0020
KOOS Sport/Rec (0–100) 30 (20, 50) 57.50 (50.00, 75.00) 25.00 (0, 45.00) 0.0195
KOOS QOL (0–100) 37.50 (25, 43.75) 50.00 (31.25, 62.50) 15.63 (6.25, 25.00) 0.0195
Data are expressed as median (IQR). Values in italics indicate significant change at the 0.05 significance level in the exploratory analyses (Wilcoxon Signed Rank
test). KOOS scored from 0 to 100, 100 = best status. NPRS scored from 0 to 10, 10 = worst pain
PFJ OA patellofemoral joint osteoarthritis, n number, NPRS numeric pain rating scale, KOOS Knee Injury and Osteoarthritis Outcome Score, ADL activity of daily
living, Rec recreation, QOL quality of life, IQR interquartile range
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the KOOS. The fair-poor retention over the 6 months of
unsupervised exercise may be an indication of low ad-
herence to the exercise program, which has been re-
ported to be common for persons with knee OA [104].
The PFJ OA group participants appeared to respond to
the supervised hip and core muscle strengthening and
core stabilization intervention, with significant short-term
improvements reported for pain, symptoms, ADL, sport/
recreation, and QOL at the conclusion of the 6-week su-
pervised program. Changes on the KOOS subscales all
surpassed the MCID of 8–10 points and were all in the
range reported to indicate true change in younger patients
treated conservatively (14.3–19.6 points) [86, 87]. In
addition, participants rated their overall status at the 6-
week follow-up as partially recovered, with the mean GRC
score exceeding the MCID. Importantly, the exercise
intervention resulted in improvements in the PFJ OA
group’s physical performance and muscle strength as well.
PFJ OA group participants completed the TUG in less
time at the 6-week follow-up compared to baseline. It is
recommended to collect pain ratings with the TUG time
score for a more complete measure of mobility [92]. The
pre- and post-TUG NPRS decreased; however, the change
was not statistically significant. This lack of significance
may be due to the relatively low baseline TUG NPRS and
the small sample size. Participants increased their hip
muscle strength, as evidenced by significantly increased
isometric hip external rotator muscle torque. Hip exten-
sor, hip abductor, and knee extensor isometric muscle
torque also increased, though not reaching statistical sig-
nificance. Improvement in hip external rotator and hip ex-
tensor isometric muscle torques increased by a median of
25 and 55%, respectively; both of these percentage im-
provements were well above the recommended minimum
important difference of 14% for hip muscles [102]. Im-
proved TUG performance may have been due to increased
LE strength, decreased pain, neural adaptation, or a com-
bination of these factors [105].
Participants in the PFJ OA group had significantly
worse pain, symptoms, QOL, and function compared to
the asymptomatic control group, consistent with earlier
studies [12, 13]. Our findings that persons with PFJ OA
have significantly worse physical performance as mea-
sured by the TUG compared to age- and sex-matched
controls is also consistent with an earlier study [13].
Time score for the TUG for PFJ OA participants was
similar (median 7.42 s for the current study, 7.5 s for the
earlier study), but the current control group median
TUG time was lower than an earlier study (median 5.
88 s current study, 6.4 s earlier study) [13]. The differ-
ence may be due to the lower median age in the current
study versus the earlier study (median 52 years and
57 years, current and earlier study, respectively) [13].
Our study adds to limited reports of reduced physical
performance in persons with PFJ OA and demonstrates
the usefulness of the TUG as a physical performance
measure in this population [91]. The TUG may be par-
ticularly useful as a physical performance measure in
persons with PFJ OA since it includes sit to stand, an ac-
tivity requiring strong quadriceps contraction with the
knee in a highly flexed position and is estimated to result
in PFJ reaction forces of 6.70 times body weight [106].
A surprising finding was that the hip extensors and
hip abductors did not significantly increase in peak iso-
metric torque, despite a focus of the program on
strengthening these muscle groups. This may be due to
the small sample size and relatively high variability of
participant torque change. Participants may also have
learned improved core stabilization, thus improving iso-
lated muscle recruitment. One component of this novel
intervention was neuromuscular education in proper
lumbopelvic-hip core stabilization during exercise. Some
hip abductor and hip extensor strengthening exercises
were similar to the isometric torque test positions for
these two muscle groups. During supervised exercise
sessions, participants were given verbal, written, and
tactile feedback to isolate gluteus medius and gluteus
maximus recruitment, and avoidance of pelvic or trunk
motion. It may be that participants focused on isolated
recruitment of gluteus medius and gluteus maximus
Table 5 PFJ OA participant peak isometric muscle torque and TUG at baseline and 6-week follow-up
Baseline 6-week follow-up Change from baseline P value
Hip Ext Rot Torque 0.16 (0.13, 0.16) 0.19 (0.17, 0.24) 0.04 (0.02, 0.08) 0.0137
Hip Abd Torque 0.33 (0.31, 0.41) 0.34 (0.28, 0.46) − 0.04 (− 0.11, 0.07) 0.6953
Hip Ext Torque 0.11 (0.07, 0.21) 0.16 (0.12, 0.38) 0.06 (−0.01, 0.10) 0.1309
Knee Ext Torque 0.43 (0.37, 0.62) 0.68 (0.37, 0.75) 0.06 (−0.03, 0.24) 0.3223
TUG (s) 7.61 ± 1.70 6.63 ± 1.36 − 0.98 ± 0.84 0.0052
Pre-TUG Pain (0–10) 2.00 (0.00, 4.00) 0 (0, 3) − 1 (−3, 0) 0.1719
Post-TUG Pain (0–10) 2.00 (1.00, 4.00) 0 (0, 3) − 2 (−3, 0) 0.1250
Data are expressed as median (IQR) except for TUG which is expressed as mean ± SD. Values in italics indicate significant change at the 0.05 significance level in
the exploratory analyses (Wilcoxon Signed Rank test [median {IQR} results] or paired t test [mean ± SD] results)
PFJ OA patellofemoral joint osteoarthritis, Ext Rot external rotator, Abd abductor, Ext extensor, TUG Timed-Up-and-Go, IQR interquartile range, SD
standard deviation
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muscles during 6-week hip abductor and hip extensor
tests, respectively. In contrast, at baseline, they may have
recruited secondary muscles to assist with performance
of these tests. This may explain the apparent lack of sig-
nificant short-term hip abductor muscle torque change,
despite participants’ ability to perform exercise with
heavier resistance loads. Since we did not collect electro-
myographic data during testing, we are unable to com-
ment on a change in muscle recruitment following the
supervised exercise intervention.
The lack of significant baseline to 6-week follow-up
change in peak isometric muscle torque for the hip ex-
tensors, hip abductors, and knee extensors may have
been due to insufficient overload of these muscles. We
did not use specific repetition maximum (RM) testing to
calculate the exercise load intensity; rather, we focused
on movement control prior to adding resistance. The
American College of Sports Medicine (ACSM) recom-
mends use of testing to determine a healthy person’s 1
RM (1-RM) level and then performing 2–4 sets of 8–12
repetitions of 60–80% of the 1-RM to improve muscle
strength [107]. The ACSM recommends beginning exer-
cise intensity at 60–70% 1-RM or use of a Rating of Per-
ceived Exertion Scale score of 5–6 (scale of 0–10, 10 =
highest exertion) in persons who are older, very decondi-
tioned, or susceptible to musculotendinous injuries
[107]. The lower exercise intensity may be most appro-
priate for persons with painful PFJ OA who are often
deconditioned, as comparison of the PFJ OA group
muscle torque baseline scores to the control group base-
line scores demonstrated (Table 3). An additional base-
line exercise intensity level which could be used is the
10 RM (10-RM) value; this is recommended in a system-
atic review reporting principles of resistance training for
persons with knee OA [105]. Although we progressed
exercise intensity through use of cuff weights, greater re-
sistance in therapeutic resistance bands, and altering
body position, we may not have overloaded the muscles
sufficiently to cause increased strength. We did follow
ACSM resistance training criteria for recommended num-
ber of sets, number of repetitions, exercise session dur-
ation, frequency of moderate exercise sessions, and
progression [107]. The lack of following ACSM criteria for
resistance exercise intensity in our study is consistent with
the findings of a systematic review of resistance training
exercise studies for persons with knee OA [105].
The findings of significant short-term improvement in
pain as measured with the NPRS and KOOS are consist-
ent with earlier studies that included LE strengthening
as part of a multimodal conservative intervention for
PFJ OA [42, 45]. The current study, which was solely an
exercise intervention, differed from earlier studies in that
it resulted in significant improvements in self-reported
ADL, QOL, and physical performance at the end of
6 weeks. Earlier studies examining conservative, multi-
modal approaches for persons with PFJ OA did not
show any change in ADL or QOL [42, 45]. Importantly,
our study is the first to report short-term improvement
in participants’ objective physical performance, time to
complete the TUG. It may be that the most important
factor in a PFJ OA rehabilitation program is a proximal
LE strengthening and core stabilization program. Earlier
multimodal approaches had less face-to-face time spent
by the physical therapist with participants and part of
the time was allocated to patellar taping and/or patellar
mobilization. Supervised sessions in the study by Quilty
et al. [42] included only 4.5 h over 10 weeks and the
study by Crossley et al. [45] included only 8 h over
12 weeks. The current study included 10 h of supervised
sessions over 5–6 weeks, which were entirely exercise
and neuromuscular reeducation of LE movement and
lumbopelvic-hip core stability. Short-term improvements
in ADL, physical performance, and QOL in our study
may have been due to the greater volume of supervised
exercise received by participants [108]. One recom-
mended method to increase strength and improve
muscle adaptations to exercise is to increase the volume
of exercise per session by increasing the number of
exercises or the number of sets of repetitions performed
[108]. It may be that the most important factor for
optimal patient outcomes is the amount of time spent
in strengthening exercise and neuromuscular reeduca-
tion for proper LE alignment and core stabilization
during functional activities. The combination of a
greater volume of exercise during exercise sessions
combined with proper exercise intensity to overload
the muscle will result in significant muscle strengthening
and even greater improvement in function and reduction
in pain [105, 107].
This study has several limitations. There was a small
sample size, as appropriate for a feasibility study; there-
fore, firm conclusions regarding the benefit of this inter-
vention should be avoided. The only comparison group
was a healthy control group; there was no intervention
comparison group. This was a feasibility study to deter-
mine if an exercise intervention for PFJ OA with a hip
and core muscle strengthening and stabilization focus
should be explored in future randomized controlled tri-
als. Due to the study design, we cannot make firm con-
clusions that the exercise intervention was the sole
cause of improved symptomatic and functional status of
the PFJ OA participants. However, this group of middle-
aged women with painful PFJ OA improved their pain
intensity, symptoms, ADL, physical performance, QOL,
and hip external rotator muscle strength in only 5–
6 weeks. The lack of use of a RM testing or a rating of
perceived exertion to determine muscle strength base-
line and proper exercise intensity, as described by the
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ACSM, limits our ability to determine if the resistive ex-
ercise strengthening program for the hip external rota-
tors, hip extensors, and hip abductors was adequate to
result in muscle strengthening [105, 107]. An additional
limitation is that the study did not include any men, al-
though it was open to both sexes. Potential participants
of both sexes were screened for participation, but the
one male screened was excluded due to co-existing
neurological and orthopedic conditions. It may be that
participants were all female since symptomatic PFJ OA
is more prevalent in females than males [11] or because
females report greater knee pain, which may make them
more interested in treatment [21]. This may limit
generalizability of our results to middle-aged females
with PFJ OA. The significant difference between the PFJ
OA and control groups for BMI is a limitation of this
study since elevated BMI is associated with PFJ OA and
patellofemoral pain [109]. Future randomized controlled
studies examining interventions for PFJ OA should con-
sider matching groups according to BMI to avoid this
limitation. Finally, although adherence to supervised ex-
ercise sessions over the 6-week intervention was good,
the long-term retention rate over 6 months and willing-
ness to respond to a 6-month follow-up questionnaire
were fair, while recording home exercise participation in
an exercise calendar diary and returning this diary was
poor. We are therefore unable to comment on the im-
pact of performance of a home exercise program on par-
ticipants’ improvement. Future studies should consider
additional methods to improve and monitor adherence
to the home exercise program, such as checking exercise
diaries at each supervised exercise session, use of auto-
mated software applications for more frequent exercise
reminders and/or for participant recording of exercise
sessions, education regarding the benefits of exercise
and physical activity for knee OA and patellofemoral
pain, and greater variety in exercise programs to im-
prove enjoyment of exercise [110–112].
Conclusions
This pilot feasibility study demonstrated that a hip and
lumbopelvic-hip core muscle strengthening and core sta-
bility exercise program is feasible as an intervention for
persons with painful PFJ OA. Participants found the ex-
ercise program acceptable and were adherent to super-
vised sessions. Long-term retention at a 6-month follow-
up was fair and return of exercise calendar diaries was
poor. The intervention appeared to result in improved
pain, function, physical performance, hip external rota-
tor muscle strength, and QOL in the short term. Long-
term results 6 months after conclusion of the interven-
tion were no longer statistically significant but reported
pain, function, and QOL were still above minimum im-
portant difference levels. The study shows that an
intervention with hip muscle strengthening and core
stabilization is appropriate to be studied in future ran-
domized controlled trials.
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